Gov. Noem’s response to concerns over state hydroxychloroquine trial
PIERRE, S.D. — Gov. Kristi Noem, alongside the Chief Medical Officer of Sanford Health, responded to concerns over the state’s trial of the drug hydroxychloroquine.
The governor says her office has been flooded with questions about the safety of the drug, and how the trial is being conducted. Doctor Allison Suttle of Sanford says the trial is to determine the drug’s effectiveness at preventing COVID-19 and is not for patients who test positive.
The focus of the study shifted after the World Health Organization issued a warning about the drug.
Suttle says South Dakota’s trial, uses doses similar to those taken to prevent malaria, and participants are screened for any potential medical issues.
“I’m not invested in if it works or if it doesn’t work, what I want to know is an answer so that we can move forward — and that’s really what we’re trying to do at all stages of the disease is look at different things that might help in terms of preventing the disease, or in terms of helping those that are very sick recover.” said Suttle.
Suttle says that Sanford hopes to enroll 2,000 people in the trial, with half receiving a placebo.
So far, she says only “A handful” of people have signed up.